Style | Citing Format |
---|---|
MLA | R Abniki REZA, et al.. "Tracking Antibiotic Resistance Trends in Central Iran Amidst the Covid‑19 Pandemic From 2021 to 2023: A Comprehensive Epidemiological Study." Advanced Biomedical Research, vol. 13, no. 1, 2024, pp. -. |
APA | R Abniki REZA, A Tashakor AMIRHOSSEIN, M Masoudi MELIKA, A Pourdad AREZOO, D Mansury DAVOOD (2024). Tracking Antibiotic Resistance Trends in Central Iran Amidst the Covid‑19 Pandemic From 2021 to 2023: A Comprehensive Epidemiological Study. Advanced Biomedical Research, 13(1), -. |
Chicago | R Abniki REZA, A Tashakor AMIRHOSSEIN, M Masoudi MELIKA, A Pourdad AREZOO, D Mansury DAVOOD. "Tracking Antibiotic Resistance Trends in Central Iran Amidst the Covid‑19 Pandemic From 2021 to 2023: A Comprehensive Epidemiological Study." Advanced Biomedical Research 13, no. 1 (2024): -. |
Harvard | R Abniki REZA et al. (2024) 'Tracking Antibiotic Resistance Trends in Central Iran Amidst the Covid‑19 Pandemic From 2021 to 2023: A Comprehensive Epidemiological Study', Advanced Biomedical Research, 13(1), pp. -. |
Vancouver | R Abniki REZA, A Tashakor AMIRHOSSEIN, M Masoudi MELIKA, A Pourdad AREZOO, D Mansury DAVOOD. Tracking Antibiotic Resistance Trends in Central Iran Amidst the Covid‑19 Pandemic From 2021 to 2023: A Comprehensive Epidemiological Study. Advanced Biomedical Research. 2024;13(1):-. |
BibTex | @article{ author = {R Abniki REZA and A Tashakor AMIRHOSSEIN and M Masoudi MELIKA and A Pourdad AREZOO and D Mansury DAVOOD}, title = {Tracking Antibiotic Resistance Trends in Central Iran Amidst the Covid‑19 Pandemic From 2021 to 2023: A Comprehensive Epidemiological Study}, journal = {Advanced Biomedical Research}, volume = {13}, number = {1}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - R Abniki REZA AU - A Tashakor AMIRHOSSEIN AU - M Masoudi MELIKA AU - A Pourdad AREZOO AU - D Mansury DAVOOD TI - Tracking Antibiotic Resistance Trends in Central Iran Amidst the Covid‑19 Pandemic From 2021 to 2023: A Comprehensive Epidemiological Study JO - Advanced Biomedical Research VL - 13 IS - 1 SP - EP - PY - 2024 ER - |